NANOFORM
LIVE

Serial Number

79388914

Owner

Nanoform Finland Oyj

Filing Date

Sep 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NANOFORM Trademark

Serial Number: 79388914 • Registration: 7490912

NANOFORM is a trademark filed by Nanoform Finland Oyj on September 21, 2023. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Nanoform Finland Oyj (6 trademarks)

Viikinkaari 4

Entity Type: 84

Trademark Details

Filing Date

September 21, 2023

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Providing information relating to material treatment; processing of biopharmaceutical materials for others, namely, custom manufacture of biopharmaceutical materials; custom manufacture of biopharmaceuticals; bioremediation services; custom manufacture of pharmaceuticals; treatment of materials by means of modification of particles using chemical and physical processing and transformation processes, namely, custom manufacturing of pharmaceuticals; provision of information relating to chemical processing being a type of chemical treatment of materials; custom manufacture of medical devices for others; microencapsulating services provided for others

Recorded bioinformatics software for capturing, computing, analyzing and interpreting biological data; apparatus for the transmission of data; apparatus for recording data; laboratory data processing apparatus for use in data collection; recorded data communications software; digital media, namely, downloadable audio and video digital recordings that contain chemical properties; electronically prerecorded digital recordings featuring data in the field of science; laboratory equipment, namely, an apparatus for detecting particles; laboratory apparatus and instruments, namely, particle size analyzers; laboratory apparatus and instruments, namely, particle flow monitors; recorded interactive databases featuring chemical properties of molecules; downloadable computer software for the management of data; downloadable computer software for analyzing drug particles relating to the medical field; nanoparticle size analysers; recorded computer data storage programs; recorded computer programmes for data processing; electronic data loggers; computer programs, recorded, for use in electronic storage of data; electronic databases in the field of pharmaceutical industry recorded on computer media; recorded computer database; search engine software; recorded computer software for database synchronization; computer documentation in electronic form, in the nature of electronic publications, namely, manuals, software documentation being a type of manual, whitepapers, magazines, and articles featuring software design and development, database management, data processing, recorded on computer media; recorded computer databases in the field of pharmaceutical industry; recorded computer database servers in the field of pharmaceutical industry; recorded computer programs for accessing, browsing and searching online databases; recorded computer software for database management; recorded computer software to automate data warehousing; recorded computer software for application and database integration; recorded computer software for creating searchable databases of information and data; recorded computer software for authorising access to data bases; electronic databases recorded on computer media in the field of pharmaceutical industry

Active chemical ingredients for use in the manufacture of pharmaceuticals; biochemical substances in the nature of biochemical preparations for scientific purposes; biochemical preparations other than for medical use; biological substances in the nature of biochemical reagents other than for medical or veterinary use; biological activators, namely, biochemical catalysts; biological inoculants, namely, biological microorganisms used in fermentation of silage, other than for medical use; biological preparations for use in industry and science; substances in the nature of plant hormones for promoting plant growth; plant growth regulating preparations; preservatives for plants; plant extracts for use in the manufacture of pharmaceuticals; chemicals for the protection of plants in the nature of plant preservatives, other than fungicides, weedkillers, herbicides, insecticides, parasiticides; nanopowders for industrial purposes; all the above goods only in the field of nanotechnology and drug particle engineering

Consultancy and information services relating to dispensing of biopharmaceutical products; consultancy and information services in the field of pharmaceutical products; provision of pharmaceutical information; advisory services in the field of pharmaceuticals; medical information services provided via the internet; rental of medical apparatus and installations in the field of medical technology; pharmacy advice, namely, pharmaceutical advice; medical counseling; medical screening; medical information; medical analysis services for the diagnosis and treatment of persons provided by a medical laboratory; providing medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; advisory services relating to medical apparatus and instruments; advisory services relating to medical problems; preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications

Scientific analysis in the field of molecular biology; analytical scientific laboratory services; advisory services relating to biochemistry; biochemistry consultancy; biochemical research and analysis; biochemical research and development; biochemical engineering services; research and development services in the field of biochemistry; scientific research relating to biology; biological research and analysis; biomedical research services; biological research laboratory services; biological research development services; biological research, clinical research in the field of pharmaceutical industry and medical research; scientific laboratory services in the nature of preparation of biological samples for testing and analysis in research laboratories; research in the field of biotechnology; consultancy relating to biotechnology; scientific and technological services, namely, scientific testing in the field of biotechnology; scientific research in the field of pharmacogenetics; consultancy relating to research in the field of pharmacogenetics; consultancy pertaining to pharmacology; pharmaceutical products development; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; testing services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product evaluation; design of particles in the processing of pharmaceutical solids; scientific laboratory services of a chemical and biological laboratory; conducting clinical trials for others; provision of information and data relating to medical and veterinary research and development; design and development of computer software for use with medical technology; medical and pharmacological research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of medical technology; consultancy relating to pharmaceutical research and development; drug discovery services; inspection of pharmaceuticals; research on the subject of pharmaceuticals; research in the field of molecular sciences; providing on-line non-downloadable software for database management; electronic storage services for archiving databases; services for the provision of technological information, namely, providing technology information in the field of pharmaceutical industry; expert opinion relating to technology, namely, technological consultation in the field of computer databases; providing information about industrial scientific analysis and scientific research services; biotechnological research relating to industry; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research for medical purposes; scientific research in the field of pharmacy; scientific research conducted using databases; providing scientific and technological information; conducting clinical trials for others in the field of pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; design and development of computer database programs; consultancy relating to the design and development of computer database programs; rental of a database server to third parties; installation, maintenance and updating of database software; reconstruction of database systems for others; design and development of software for database management; database design and development; development, updating and maintenance of software and database systems; server hosting of databases; server hosting of computerized data, files, applications and information; writing of computer programs for medical applications; computer programming in the medical field; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting early evaluations in the field of new pharmaceuticals

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 3, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 8, 2024 GPNX
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 13, 2024 OP2R
NOTICE OF PUBLICATION
May 29, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
ASSIGNED TO EXAMINER
May 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 13, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2024 REPR